Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study

• Published in: Experimental & molecular medicine pp. 1 - 7
• Main Authors: Elena Maria Yubero-Serrano, Javier Delgado-Lista, Patricia Pena-Orihuela, Pablo Perez-Martine, Francisco Fuentes, Carmen Marin, Isaac Tunez, Francisco Jose Tinahones, Francisco Perez-Jimenez, Helen M Roche, Jose Lopez-Miranda
• Format: Journal Article
• Language: English
• Published: 생화학분자생물학회 01.06.2013
• Subjects: 생화학
• ISSN: 1226-3613; 2092-6413

Previous evidence supports the important role that oxidative stress (OxS) plays in metabolic syndrome (MetS)-related manifestations. We determined the relationship between the number of MetS components and the degree of OxS in MetS patients. In this comparative cross-sectional study from the LIPGENE cohort, a total of 91 MetS patients (43 men and 48women; aged between 45 and 68 years) were divided into four groups based on the number of MetS components: subjects with 2, 3, 4 and 5 MetS components (n¼20, 31, 28 and 12, respectively). We measured ischemic reactive hyperemia (IRH),plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), total nitrite, lipid peroxidation products (LPO), hydrogen peroxide (H2O2), superoxide dismutase (SOD) and glutathione peroxidase (GPx) plasma activities. sVCAM-1, H2O2 and LPO levels were lower in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. IRH and total nitrite levels were higher in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. SOD and GPx activities were lower in subjects with 2 MetS components than subjects with 4 or 5 MetS components. Waist circumference,weight, age, homeostatic model assessment-b, triglycerides (TGs), high-density lipoprotein and sVCAM-1 levels were significantly correlated with SOD activity. MetS subjects with more MetS components may have a higher OxS level. Furthermore, association between SOD activity and MetS components may indicate that this variable could be the most relevant OxS biomarker in patients suffering from MetS and could be used as a predictive tool to determine the degree of the underlying OxS in MetS. KCI Citation Count: 43